9/21/2017

Investigational Gout Drugs Do Well in Clinical Trials

Investigational Gout Drugs Do Well in Clinical Trials

Two major American drug companies are racing to get rival new gout medications to market. Both gout medicines take novel approaches to treating refractory gout - gout that hasn't already responded well to current treatment.

Ardea Biosciences had been the first one to announce productive clinical trials of its experimental gout drug RDEA594, also known as Lesinurad. Lesinurad's mechanism of action is different from that of the commonly prescribed xanthine oxidase inhibitors gout medications (such as allopurinol and febuxostat), which decrease the assembly of uric acid.

Lesinurad is often a URAT1 transporter inhibitor which usually boosts refraining from uric acid with the kidneys. Lesinurad is also active in opposition to another important regulator of urate secretion, OAT4. OAT4 is thought to be responsible for the high uric acid levels in gouty arthritis patients whose condition is caused or worsened by diuretics.

The Lesinurad study involved 208 gout patients who had high blood urate levels for at least Six months, even while taking the gout drug allopurinol. Individuals continued on allopurinol and were randomly assigned to receive either a placebo or lesinurad at doses of 200 mg, 400 mg, or 600 mg for four weeks.

All three groups who were given lesinurad showed considerably lower uric acid levels at the end of the month. The percentage of patients who achieved the target for uric acid levels after treatment was 28% in the placebo group, 71% in the 200 mg team, 76% in the 400 mg party, and 87% in the 600 mg group.

The Best Remedies for High Uric Acid

The Best Remedies for High Uric Acid

Goutezol Gout Relief contains herbal ingredients formulated to gently support healthy uric acid metabolism. Goutezol's ingredients have been used for many years to support healthy uric acid metabolism, helping in reducing high uric acid levels. Now they are all integrated into this unique gout formula. Reducing uric acid and supporting uric acid metabolism has been shown to ease the flare-ups related to gout.
Click Here to Purchase »

More recently, shares of BioCryst Pharmaceuticals rose 12% upon the release of the results of its phase 2b randomized, double-blind, study with the investigational gout drug BCX4208. BCX4208 is really a novel enzyme inhibitor that acts upstream of xanthine oxidase in the purine metabolism path to reduce serum uric acid (sUA).

Gout ¦ Definition, Causes, Symptoms and Treatment

gout definition causes symptoms treatment Gout Treatment and Symptoms gout treatment النقرس gout definition, gout pdf, gout ppt, gout symptoms, gout ...

  • Natural Arthritis Medication to the Rescue!Natural Arthritis Medication to the Rescue! Copyright 2005 Wendy OwenNo matter which type of arthritis you suffer from, be it osteoarthritis, gout, fibromyalgia, rheumatoid arthritis or any one of the myriad forms of this disease, you need a safe and effective treatment. Attention is...
  • Its mechanism of action complements xanthine oxidase inhibitors like allopurinol and also febuxostat in reducing uric acid production, and BCX4208 is intended as an add-on therapy for those gouty joint disease patients who do not respond well in order to current gout medication.

    Like Lesinurad, BCX4208 was studied in gouty arthritis patients who had experienced high blood urate levels for at least 6 months, despite taking the gout drug allopurinol. The 279 study participants were randomly assigned to take BCX4208 at doses of both 5 mg, 10 mg, 20 mg, or 40 mg once daily for 12 weeks. One group of individuals was given a placebo. Just about all participants were also given allopurinal 300 mg once-daily.

    • All but one of the doses showed that BCX4208 was superior to the placebo when obtained with allopurinol.
    • The BCX4208 doses evaluated in the study showed response rates ranging from 33% to 49%, compared to 18% for those taking the placebo.
    At this point, Lesinurad appears the more promising of the two gout drugs, and the most likely to hit the market first. It outperformed BCX4208 in early clinical trials, and is farther ahead in the development and approval process. But individual responses to drugs vary, and gout patients will benefit from having two new approaches to relieving the symptoms of this painful condition.

    Alex Ray Advocates for Affordable Access to Healthcare and Medication

    She recommends Big Mountain Drugs as a reliable online Canadian pharmacy from which to buy allopurinol and colchicine for gout. For more information about gout and gout medication, look at the on the internet resource www.colchicine.ca.

    Susie HartSusie Hart
    Susie is a leading curator at omex3.com, a resource about alternative natural health. Last year, Susie worked as a post curator at a well-known tech web site. When she's not sourcing web posts, Susie enjoys working out and skateboarding.